What is Johnson & Johnson's market cap?

Johnson & Johnson (JNJ) has a market capitalization of $643.30B and trades on NYSE.

What is Johnson & Johnson's revenue and profitability?

Johnson & Johnson generated $96.4B in trailing twelve-month revenue with net income of $21.0B, representing a net margin of 21.8%. Gross margin stands at 67.8%, with free cash flow of $17.8B. These figures are based on the Q1 2026 filing.

Who are Johnson & Johnson's competitors?

Johnson & Johnson's key competitors include Merck & Co., Stryker, Pfizer, and others. These companies compete in similar markets and product categories.

Who does Johnson & Johnson partner with?

Johnson & Johnson's notable partners include Genmab A/S, AbbVie, Bristol-Myers Squibb, and others.

Where is Johnson & Johnson headquartered?

Johnson & Johnson is headquartered in United States of America and employs approximately 134,400 people. It has been publicly traded since 1944.

Johnson & Johnson

JNJ

Johnson & Johnson is a global healthcare leader focused on the research, development, and manufacture of products dedicated to human health and well-being.

Market cap

$643.3B+71.4%

Revenue$96.4B+7.9%

Net income$21.0B-3.5%

Free cash flow$17.8B-12.7%

EPS (diluted)$8.64-3.9%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 14, 2026

Revenue$24.1BBeat by $447.3M EPS$2.70Beat by $0.02

Read the full report

Next report

Jul 15, 2026 (In 6 days)

Revenue estimate$25.0B

EPS estimate$2.83

Financials

Q1 2026

Income statement

See full

Revenue$24.1B+9.9%

Gross profit$16.0B+9.8%

Operating income$6.3B+2.3%

Net income$5.2B-52.4%

EPS (diluted)$2.14-52.9%

Balance sheet

See full

Cash & equivalents$21.7B-43.6%

Total debt$55.0B+5.2%

Total equity$81.2B+3.9%

Total assets$200.89B+3.7%

Cash flow

See full

Operating cash flow$2.5B-39.8%

CapEx$1.0B+31.9%

Free cash flow$1.5B-56.6%

Valuation & ratios

Valuation

See full

Market cap$643.3B+71.4%

Enterprise value$676.6B+66.5%

P/E30.6×+14.1×

P/S6.7×+2.5×

Profitability

See full

Gross margin67.8%-0.5pp

Operating margin26.4%+2.8pp

Net margin21.8%-2.6pp

FCF margin18.5%-4.3pp

Returns & leverage

See full

Return on equity26.4%-3.0pp

Debt / equity0.7×0.0×

Current ratio1×-0.2×

Segments

By product

See full

DARZALEX$4.0B+22.5%

Other$2.9B+2.1%

Tremfya$1.6B+68.2%

GENERAL$1.4B+4.9%

ADVANCED$1.1B+4.7%

By geography

See full

Europe$5.8B+14.4%

Asia-Pacific, Africa$3.6B+8.5%

Western Hemisphere, excluding U.S.$1.3B+10.8%

By segment

See full

Innovative Medicine$15.4B+11.2%

MEDTECH$8.6B+7.7%

Competitors

By market cap

Johnson & Johnson$643.30B+71.9%

AbbVie$449.91B+33.5%

Merck & Co.$318.26B+53.8%

Amgen$198.67B+24.5%

Pfizer$137.19B-4.7%

Stryker$126.41B-15.6%

Bristol-Myers Squibb$118.38B+22.1%

Opko Health$1.1B+5.9%

By revenue growth

AbbVie+9.5%

Amgen+9.1%

Stryker+8.8%

Johnson & Johnson+7.9%

Merck & Co.+2.9%

Bristol-Myers Squibb+1.8%

Pfizer+1.4%

Opko Health-15.7%

By net margin

Johnson & Johnson21.83%-2.6pp

Amgen20.96%+3.6pp

Pfizer15.65%+6.3pp

Bristol-Myers Squibb15.01%+3.8pp

Merck & Co.13.59%-13.7pp

Stryker13.21%+0.9pp

AbbVie5.79%-1.5pp

Opko Health-36.64%-31.0pp

Profile

Johnson & Johnson is a global healthcare leader focused on the research, development, and manufacture of products dedicated to human health and well-being. The company operates as a holding company with a diverse portfolio spanning advanced pharmaceutical therapies and medical technologies. Its core value proposition lies in delivering innovative clinical solutions across a broad range of therapeutic areas and surgical specialties.

Competitive position

A leading global healthcare entity with significant market share in oncology and immunology, characterized by a massive R&D pipeline and a dominant position in the medical device market.

GeographiesUnited States, Europe, Asia-Pacific, Latin America

Customer segmentsHealthcare providers, Medical distributors, Government health programs

Business modelR&D-driven manufacturing, Intellectual property licensing, B2B distribution

SuppliersRaw material suppliers, Contract research organizations, Specialized chemical providers, Biotechnology patent licensors

CustomersPharmacy benefit managers, Governmental payers (Medicare/Medicaid), Private insurance companies, Hospital procurement networks

CountryUnited States of America

Listed1944

Employees134.4K

CEOJoaquin Duato

SectorHealthcare

IndustryDrug Manufacturers - General

Websitejnj.com

FilingsSEC EDGAR

Ask your AI about Johnson & Johnson.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Johnson & Johnson's market cap?: Johnson & Johnson (JNJ) has a market capitalization of $643.30B and trades on NYSE.
What is Johnson & Johnson's revenue and profitability?: Johnson & Johnson generated $96.4B in trailing twelve-month revenue with net income of $21.0B, representing a net margin of 21.8%. Gross margin stands at 67.8%, with free cash flow of $17.8B. These figures are based on the Q1 2026 filing.
Who are Johnson & Johnson's competitors?: Johnson & Johnson's key competitors include Merck & Co., Stryker, Pfizer, and others. These companies compete in similar markets and product categories.
Who does Johnson & Johnson partner with?: Johnson & Johnson's notable partners include Genmab A/S, AbbVie, Bristol-Myers Squibb, and others.
Where is Johnson & Johnson headquartered?: Johnson & Johnson is headquartered in United States of America and employs approximately 134,400 people. It has been publicly traded since 1944.